Mr. Joseph J. Chivini
Austin Chemical Company, Inc.
1565 Barclay Boulevard
Buffalo Grove, IL 60089
RE: The tariff classification of Deferoxamine Mesylate (CAS#
138-14-7), imported in bulk form, from India
Dear Mr. Chivini:
In your letter dated July 13, 1998, you requested a tariff
The subject product, Deferoxamine Mesylate, is an iron-chelating agent indicated for the treatment of acute iron
intoxification and of chronic iron overload due to transfusion-dependent anemias.
The applicable subheading for Deferoxamine Mesylate,
imported in bulk form, will be 2928.00.3000, Harmonized Tariff
Schedule of the United States (HTS), which provides for: "Organic
derivatives of hydrazine or of hydroxylamine: Other: Other:
Drugs." Pursuant to General Note 13, HTS, the rate of duty will
This merchandise may be subject to the requirements of the
Federal Food, Drug, and Cosmetic Act, which is administered by
the U.S. Food and Drug Administration. You may contact them at
5600 Fishers Lane, Rockville, Maryland 20857, telephone number
This ruling is being issued under the provisions of Part 177
of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above
should be provided with the entry documents filed at the time
this merchandise is imported. If you have any questions
regarding the ruling, contact National Import Specialist Harvey
Kuperstein at 212-466-5770.
Robert B. Swierupski